| 1.86 0.18 (10.71%) | 03-06 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.25  |
1-year : | 2.63 |
| Resists | First : | 1.92 |
Second : | 2.25 |
| Pivot price | 1.32 |
|||
| Supports | First : | 1.35 |
Second : | 0.99 |
| MAs | MA(5) : | 1.59 |
MA(20) : | 1.26 |
| MA(100) : | 1.7 |
MA(250) : | 1.67 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 93 |
D(3) : | 94.6 |
| RSI | RSI(14): 79.2 |
|||
| 52-week | High : | 7.59 | Low : | 0.51 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ HIT ] has closed above the upper band by 7.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 13% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.93 - 1.94 | 1.94 - 1.94 |
| Low: | 1.59 - 1.59 | 1.59 - 1.6 |
| Close: | 1.85 - 1.86 | 1.86 - 1.87 |
Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small to medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.
Sun, 22 Feb 2026
HIT - Health In Tech, Inc. Latest Stock News & Market Updates - Stock Titan
Fri, 06 Feb 2026
Health In Tech (NASDAQ:HIT) Trading Down 5.7% - Should You Sell? - MarketBeat
Thu, 29 Jan 2026
Risks Still Elevated At These Prices As Health In Tech, Inc. (NASDAQ:HIT) Shares Dive 35% - simplywall.st
Tue, 02 Dec 2025
Health In Tech (Nasdaq: HIT) leaders extend lock-up to June 20, 2026 - Stock Titan
Mon, 10 Nov 2025
Earnings call transcript: Health In Tech Q3 2025 sees 90% revenue growth - Investing.com
Mon, 10 Nov 2025
Health In Tech Announces Third Quarter 2025 Financial Results - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 45 (M) |
| Shares Float | 11 (M) |
| Held by Insiders | 74.5 (%) |
| Held by Institutions | 2.5 (%) |
| Shares Short | 270 (K) |
| Shares Short P.Month | 426 (K) |
| EPS | 0.01 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.3 |
| Profit Margin | 4.6 % |
| Operating Margin | 5.8 % |
| Return on Assets (ttm) | 5.3 % |
| Return on Equity (ttm) | 11.9 % |
| Qtrly Rev. Growth | 90.4 % |
| Gross Profit (p.s.) | 0.45 |
| Sales Per Share | 0.67 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 10.3 % |
| Operating Cash Flow | 2 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 93 |
| PEG Ratio | 0 |
| Price to Book value | 6.19 |
| Price to Sales | 2.73 |
| Price to Cash Flow | 39.11 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|